Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling

Approximately 30% of epileptic patients develop Drug-Resistant Epilepsy. Based on evidence that shows a loss of efficacy in some sodium channel blocker antiseizure drugs in epilepsy, we focus our study on assessing the anticonvulsant efficacy of different sodium channel blockers on carbamazepine (CB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zavala-Tecuapetla, Cecilia, Manjarrez-Marmolejo, Joaquín, Ramírez-Jarquín, Josué Orlando, Rivera-Cerecedo, Claudia Verónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139658/
https://www.ncbi.nlm.nih.gov/pubmed/35625015
http://dx.doi.org/10.3390/brainsci12050629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139658/
https://www.ncbi.nlm.nih.gov/pubmed/35625015
http://dx.doi.org/10.3390/brainsci12050629

Ejemplares similares